Centene (CNC) Valuation Check After Recent Share Price Momentum Shift

Like
Comment
Favorite

Centene (CNC) Valuation Check After Recent Share Price Momentum Shift

Simply Wall St.01-15

AdvertisementWhy Centene (CNC) Is Back on Investors’ Radar Centene (CNC) has drawn fresh attention after a period of contrasting returns, with gains over the past month and past 3 months sitting ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2603674655?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/26273-main-header/1756252774034","is_english":true,"pubTime":"2026-01-15 11:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603674655","market":"hk","top_or_hot":-1,"title":"Centene (CNC) Valuation Check After Recent Share Price Momentum Shift","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementWhy Centene (CNC) Is Back on Investors’ Radar Centene (CNC) has drawn fresh attention after a period of contrasting returns, with gains over the past month and past 3 months sitting ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-cnc/centene/news/centene-cnc-valuation-check-after-recent-share-price-momentu\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Centene (CNC) Valuation Check After Recent Share Price Momentum Shift</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCentene (CNC) Valuation Check After Recent Share Price Momentum Shift\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-15 11:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-cnc/centene/news/centene-cnc-valuation-check-after-recent-share-price-momentu><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementWhy Centene (CNC) Is Back on Investors’ Radar Centene (CNC) has drawn fresh attention after a period of contrasting returns, with gains over the past month and past 3 months sitting ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-cnc/centene/news/centene-cnc-valuation-check-after-recent-share-price-momentu\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1201861249.SGD","symbol_name":"Natixis Harris Associates US Equity PA SGD-H","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cnc/centene/news/centene-cnc-valuation-check-after-recent-share-price-momentu","article_id":"2603674655","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/26273-main-header/1756252774034"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cnc/centene/news/centene-cnc-valuation-check-after-recent-share-price-momentu","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2603674655","pubTimestamp":1768448230,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Why Centene (CNC) Is Back on Investors’ Radar\nCentene (CNC) has drawn fresh attention after a period of contrasting returns, with gains over the past month and past 3 months sitting beside a negative 1 year total return and multi year declines.\nSee our latest analysis for Centene.\nWith the share price at US$46.17, Centene’s recent 30 day share price return of 14.14% and 90 day gain of 29.55% sit against a 1 year total shareholder return decline of 26.89%. This suggests near term momentum has...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","LU0648000940.SGD":"Natixis Harris Associates Global Equity RA SGD","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","CNC":"康西哥","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","BK4585":"ETF&股票定投概念","LU0130518102.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"R\" INC","LU0477156797.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"RE\" (USD) ACC","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU0477156953.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"RE\" (USD) ACC","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","BK4588":"碎股","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","BK4154":"管理型保健护理","LU1699723380.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"AP\" (USD) ACC","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD"},"translate_title":"Centene(CNC)近期股价势头转变后的估值检查","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CNC":1.5},"content_text":"AdvertisementWhy Centene (CNC) Is Back on Investors’ Radar Centene (CNC) has drawn fresh attention after a period of contrasting returns, with gains over the past month and past 3 months sitting beside a negative 1 year total return and multi year declines. See our latest analysis for Centene. With the share price at US$46.17, Centene’s recent 30 day share price return of 14.14% and 90 day gain of 29.55% sit against a 1 year total shareholder return decline of 26.89%. This suggests near term momentum has picked up while longer term returns remain weak. If Centene’s move has you rethinking healthcare exposure, this can be a useful moment to scan healthcare stocks for other names showing different risk and return profiles. With Centene trading at US$46.17, showing an intrinsic value gap of about 22% and still carrying multi year negative returns, is this an undervalued healthcare stock or a company where the market is already pricing in future growth? Most Popular Narrative: 12.3% Overvalued The most followed narrative aligns a fair value of about US$41.12 with Centene’s last close at US$46.17, highlighting a valuation gap that depends on future execution. Analysts have raised their implied fair value estimate for Centene to about US$41 from roughly US$40, reflecting a mix of higher price targets tied to recent earnings results and expectations for margin recovery in Marketplace and Medicaid, partially balanced by concerns around Medicaid trends and contract losses. Read the complete narrative. Want to see what is sitting underneath that fair value estimate? Revenue runway, slim margins and a future earnings multiple are the key factors in this view. Result: Fair Value of $41.12 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, there are still clear pressure points, including policy uncertainty around Medicaid rates and ACA subsidies, as well as medical cost volatility such as unexpected flu related expenses. Find out about the key risks to this Centene narrative. Another View: What The Market Multiple Is Saying Our DCF model indicates that Centene is trading at a steep discount, with the share price of US$46.17 sitting about 78% below an estimated fair value of US$212.50. That contrasts with the US$41.12 narrative fair value that suggests the stock is overvalued. When the gap is this wide, investors may want to carefully consider which signal they find more informative. Look into how the SWS DCF model arrives at its fair value. CNC Discounted Cash Flow as at Jan 2026 Build Your Own Centene Narrative If you look at the numbers and reach a different conclusion, or prefer to test your own assumptions, you can build a custom view in just a few minutes by starting with Do it your way. A great starting point for your Centene research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision. Looking for more investment ideas? If Centene has you thinking more broadly about where to put your money to work, do not stop here. Widen your search before the next move passes you by.  Spot early stage opportunities by checking out these 3531 penny stocks with strong financials that already show stronger financial footing than many investors expect from low priced names. Tap into the AI trend through these 25 AI penny stocks that connect artificial intelligence themes with companies that meet your own risk and return preferences. Zero in on value focused ideas using these 884 undervalued stocks based on cash flows to see which companies the model flags as trading below what their cash flows might justify.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}